Twin Tree Management LP Invests $79,000 in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Twin Tree Management LP purchased a new position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,991 shares of the company’s stock, valued at approximately $79,000.

A number of other large investors have also bought and sold shares of the stock. Corient Private Wealth LLC grew its holdings in Acadia Healthcare by 19.8% in the fourth quarter. Corient Private Wealth LLC now owns 11,426 shares of the company’s stock worth $453,000 after purchasing an additional 1,892 shares during the period. one8zero8 LLC acquired a new stake in Acadia Healthcare in the fourth quarter worth $1,742,000. Natixis Advisors LLC grew its holdings in Acadia Healthcare by 0.7% in the fourth quarter. Natixis Advisors LLC now owns 195,291 shares of the company’s stock worth $7,743,000 after purchasing an additional 1,302 shares during the period. Fore Capital LLC acquired a new stake in Acadia Healthcare in the fourth quarter worth $1,190,000. Finally, Swiss National Bank grew its holdings in Acadia Healthcare by 0.8% in the fourth quarter. Swiss National Bank now owns 182,568 shares of the company’s stock worth $7,239,000 after purchasing an additional 1,400 shares during the period.

Wall Street Analysts Forecast Growth

ACHC has been the subject of a number of analyst reports. KeyCorp reduced their price objective on shares of Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating for the company in a report on Monday, March 3rd. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price objective for the company from $45.00 to $75.00 in a report on Thursday, December 12th. Barclays cut shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and reduced their price objective for the company from $43.00 to $35.00 in a report on Friday, February 28th. Bank of America reduced their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a report on Friday, February 28th. Finally, TD Cowen reduced their price objective on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $56.31.

Acadia Healthcare Stock Up 0.4 %

ACHC opened at $29.26 on Thursday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The company’s 50-day moving average is $39.20 and its 200 day moving average is $47.45. Acadia Healthcare Company, Inc. has a fifty-two week low of $27.61 and a fifty-two week high of $82.41. The firm has a market capitalization of $2.72 billion, a P/E ratio of 9.59, a PEG ratio of 1.46 and a beta of 1.38.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.